Literature DB >> 2246028

Development of genetic hypertension. Is there a "critical phase"?

T Unger, R Rettig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246028     DOI: 10.1161/01.hyp.16.6.615

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  5 in total

1.  Evidence for a major gene influencing 7-year increases in diastolic blood pressure with age.

Authors:  L S Cheng; D Carmelli; S C Hunt; R R Williams
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

2.  Effect of prolonged administration of a urinary kinase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats.

Authors:  H Ito; M Majima; S Nakajima; I Hayashi; M Katori; T Izumi
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

3.  Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.

Authors:  Yukiko Nagai; Li Yao; Hiroyuki Kobori; Kayoko Miyata; Yuri Ozawa; Akira Miyatake; Tokihito Yukimura; Takatomi Shokoji; Shoji Kimura; Hideyasu Kiyomoto; Masakazu Kohno; Youichi Abe; Akira Nishiyama
Journal:  J Am Soc Nephrol       Date:  2005-01-12       Impact factor: 10.121

4.  Prevention by blockade of angiotensin subtype1-receptors of the development of genetic hypertension but not its heritability.

Authors:  P Madeddu; V Anania; M V Varoni; P P Parpaglia; M P Demontis; M C Fattaccio; D Palomba; D Pollock; N Glorioso
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

5.  Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense.

Authors:  S N Iyer; D Lu; M J Katovich; M K Raizada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.